NEW YORK, NY / ACCESS Newswire / February 2, 2026 / Iron Dome Acquisition I Corp. ("IDAC"), a blank check company ...
Eikon Therapeutics, Inc. ('Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing important, ...
On Jan. 30, 2026, K2 Capital Acquisition Corporation (NASDAQ:KTWOU) (the "Company") announced the closing of its upsized ...
Agomab Therapeutics NV (Nasdaq: AGMB) ('Agomab”), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an ...
Foraker and Garner got involved with Once Upon a Time after discovering the baby food brand launched by Cassandra Curtis and Ari Raz. The brand's focus on fresh and organic ingredients appealed to ...
Veradermics Inc., a late clinical-stage biopharmaceutical company focused on hair restoration, raised $256.3 million in an ...
Learn how to evaluate new IPOs, understand valuation methods, and decide if you should invest. Key questions can help you assess potential stocks.
NEW YORK, NY / ACCESS Newswire / January 29, 2026 / On January 28, 2026, GigCapital9 Corp. closed its Initial Public ...
Helix Acquisition Corp. III (Nasdaq: HLXC) (the “Company”) announced today that on January 26, 2026, it closed the initial public offering of 17,250,000 Class A ordinary shares, which includes ...
SpyGlass Pharma, Inc. (Nasdaq: SGP) ("SpyGlass Pharma"), a late-stage biopharmaceutical company, today announced the pricing of its initial public ...
The world’s richest man Elon Musk is combining his companies SpaceX and xAI in a deal that values the enlarged entity at ...
TYSONS CORNER, Va.--(BUSINESS WIRE)-- Strategy Inc (MSTR) today announced that, subject to market and other conditions, it intends to conduct an initial public offering registered under the Securities ...